Conference Overview
This week-long medical education program is intended for practicing otolaryngologists, otologists/neurotologists, neurologists/neurosurgeons, neuroradiologists and audiologists. It will provide a comprehensive overview of inner ear diseases/disorders and their treatments. Basic and clinical researchers will present lectures and conduct plenary sessions on clinical ramifications of inner ear pathophysiology, state-of-the-art interventions, inner ear organ culture techniques, hair cell regeneration, inner ear fluid dynamics and their alterations in pathophysiologic disorders, and autoimmune inner ear disease.
Objectives:
At the conclusion of this activity, the participant will be able to:
- Describe the pathophysiology of inner ear disorders
- Identify and discuss appropriate medical and/or surgical treatment regimens for Ménière’s disease and other diseases of the inner ear, including tinnitus
- Assess the indications and basic interpretations of diagnostic findings for vertiginous patients
- Review implantable hearing devices and cochlear implants
- Understand inner ear fluid dynamics and homeostasis in the normal and hydropic inner ear
- Describe the three-dimensional spatial organization of the membranous labyrinth
- Utilize the video Head Impulse Test (vHIT) of all semicircular canals properly and be able to identify artifacts and errors and interpret results
- Review the physiological basis and clinical interpretation of the new tests of otolith function: oVEMPS and cVEMPS
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the University of Arkansas for Medical Sciences and Prosper Meniere Society.
University of Arkansas for Medical Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
AMA Credit Designation Statement
The University of Arkansas for Medical Sciences designates this live activity for a maximum of 24 AMA PRA Category
1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ANCC Credit Designation Statement
The University of Arkansas for Medical Sciences designates this live activity for a maximum of 24 ANCC contact hours. Nursing contact hours will be awarded for successful completion of program components based upon documented attendance and completion of evaluation materials.
Executive Director, Prosper Ménière Society John Dornhoffer, M
Agenda
Saturday, March 11
Registration – 4:30 p.m. – 6:30 p.m.
Sunday, March 12
Breakfast – 7 a.m.
MORNING SESSION: RETROSPECTIVE AND OTHER PERSPECTIVES
7:30-7:45 a.m. Welcome and Introductions-John Dornhoffer, M.D.
7:45-8:00 a.m. Prosper Ménière’s Society Founders (video presentation)-Irv Arenberg, M.D.
8:00-8:30 a.m. Ménière’s Disease in German Textbooks in the 1920’s, 30’s, and 40’s-Konrad Schwager, M.D. 8:30-9:00 a.m. Prosper Ménière’s Many-headed Hydra-Stephen Spring
9:00-9:30 a.m. Endolymphatic Sac Pathologies in Ménière’s Disease: Associated Radiological and Clinical Features, Prognostic Disease Markers, and Key to Pathogenesis-Andreas Eckhard, M.D.
EVENING SESSION: BASIC SCIENCE
4:30-5:00 p.m. A Relook at the Evidence Supporting the Viral Theory of the Pathogenesis of Endolymphatic Hydrops in Ménière’s Disease: Ultrastructural, DNA-PCR, Serologic and Epidemic Population Studies (video presentation)-Irv Arenberg, M.D.
5:00-5:30 p.m. Clearing the Complexity-Stephen Spring
5:30-6:00 p.m. Towards a Holistic Model for Hydrodynamic Pressure Regulation in the Mammalian Cochlea: Clues from Summating Basilar Membrane Responses to Sound Plus Micropuncture Pressure Experiments-Eric Le Page, Ph.D.
6:00-6:30 p.m. Third Window Syndrome: Model of Superior Semicircular Dehiscence-induced Impaired Decision- making-P. Ashley Wackym, M.D.
Dinner – 7:30 p.m.
Monday, March 13
Breakfast – 7 a.m.
MORNING SESSION: BASIC SCIENCE WITH A VIEW TOWARD ENDOLYMPHATIC HYDROPS
7:30-8:00 a.m. An in vivo Mouse Model for Endolymphatic Hydrops using 9.4T-MRI: Many Different Mechanisms Can Induce Hydrops-Mikael Karlberg, M.D.
8:00-8:30 a.m. Endolymphatic Hydrops: Detrimental or Beneficial? New Insights From Animal Models and Human Temporal Bones-Andreas Eckhard, M.D.
8:30-9:00 a.m. Revisiting the Relationship Between Endolymphatic Hydrops and Ménière’s Disease-
Michael Gluth, M.D.
9:00-9:30 a.m. Longitudinal Assessment of Endolymphatic Hydrops by 3T-MRI. The role in the Managment of Ménière´s Disease-Pedro Araüjo, M.D.
EVENING SESSION: UNIQUE APPROACHES AND INSIGHTS
4:30-5:00 p.m. Redirecting Ménière’s Syndrome (MS) to Ménière’s Disease (MD) by a Simple Pathophysiologic Explanation-Stefan Hegeman, M.D.
5:00-5:30 p.m. Phenotyping the p. Pro51Ser Variant in COCH. A Comprehensive Genotype-Phenotype Correlation Study-Sebastian Janssens de Varebeke, M.D.
5:30-6:00 p.m. The Risk of Benign Paroxysmal Vertigo After Head Trauma AND Treatment of Horizontal Canal BPPV-a Randomized Sham-Controlled Trial Comparing Two Theraputic Manuevers of Different Speeds-Karl Nordfalk, M.D.
6:00-6:30 p.m. New Model of Superior Semicircular Canal Dehiscence with Reversible Diagnostic Findings Characteristic of Patients with the Disorder-P. Ashley Wachym, M.D.
Welcome Reception – 7 p.m.
Dinner – 7:30 p.m.
Tuesday, March 14
Breakfast – 7 a.m.
MORNING SESSION: SURGERY
7:30-8:00 a.m. Vibrant Soundbridge in Atresia-John Martin Hempel, M.D.
8:00-8:30 a.m. Stapes and Stapes Revision Surgery: Preoperative Air-Bone Gap is a Prognostic Marker-
Kariem-Noureldin Sharaf, M.D.
8:30-8:45 a.m. Revision Stapes Surgery: Intraoperative Findings, Individual Solutions and Clinical Results-
Joachim Müller, M.D.
8:45-9:00 a.m. Benefit and Satisfaction of Bilateral CI Users: An Update After 25 Years of Bilateral Cochlear Implantation-Joachim Müller, M.D.
9:00-9:30 a.m. Surgery on the Only’s-David White, M.D.
EVENING SESSION: COCHLEAR IMPLANTS
4:30-5:00 p.m. Morphology of the Cochlea and its Relevance for an Individualized Cochlear Implantation-
Joachim Müller, M.D.
5:00-5:30 p.m. Structure and Hearing Preservation in Cochlear Implant Surgery-a Meta Analysis-
Hans Thomeer, M.D.
5:30-6:00 p.m. Computational Modeling of Potassium Transport in the Inner Ear-Robert Raphael, Ph.D. 6:00-7:30 p.m. Ear Bingo
Moderator: Joachim Müller, M.D.
Case Presentations by: John Martin Hempel, Joachim Müller, Veronika Volgger, Florian Schrötzmair
Panelists: John Dornhoffer, Julia Dlugaiczyk, John Martin Hempel, Konrad Schwager, Veronika Volgger
Dinner – 8 p.m.
Wednesday, March 15
Breakfast – 7 a.m.
MORNING SESSION: COCHLEAR IMPLANTS
7:30-8:00 a.m. Cochlear Implant Device Use in Prelingually Deaf Children-Phil Bird, M.D.
8:00-8:30 a.m. A Survey Examining Recent Trends in Cochlear Implant Securing Techniques-Graham Strub, M.D. 8:30-9:00 a.m. Update Management of Intralabyrinthine Schwannomas Including Subtotal Cochleoectomy and
Hearing Rehabilitation with Cochlear Implants-Stefan Plontke, M.D.
9:00-9:30 a.m. Prevalence of Endolymphatic Hydrops in Cochlear Implant Candidates with Idiopathic Profound Sensorineural Hearing Loss-Julia Dlugaiczyk, M.D.
9:30-10:00 a.m. Business meeting
EVENING SESSION: COMPREHENSIVE FINDINGS
4:30-5:00 p.m. Establishing Best Practices: Ménière’s Disease Clinical Practice Guidelines-Brian McKinnon, M.D. 5:00-5:30 p.m. On the Sites of Origin of Symptoms in Vestibular Migraine-Michael Teixido, M.D.
5:30-6:30 p.m. Keynote: History and Overview of Third Window Syndrome-P. Ashley Wackym, M.D.
Dinner and Awards Ceremony – 7:30 p.m.
Thursday, March 16
Breakfast – 7 a.m.
MORNING SESSION: TINNITUS AND IMAGING
7:30-8:00 a.m. Tonic Tensor Tympani Syndrome: Prevalence and Management Outcomes in a General Hospital ENT Clinic in Singapore-Linette, Tan, M.D.
8:00-8:30 a.m. A Novel Three-Step Process for the Identification of Inner Ear Malformation Types-
Anandhan Dhanasingh, M.D.
8:30-9:00 a.m. Magnetic Resonance Spectroscopy in Tinnitus: Neurochemistry of the Human Auditory Cortex in Patients with Chronic Tinnitus-Tobias Kleinjung, M.D.
9:00-9:30 a.m. Frequency-specific Electrocochleography and Traveling Wave Time as a Clinical Test for Disease-
Robert Conway, D.O.
EVENING SESSION: TINNITUS AND DIAGNOSIS
4:30-5:00 p.m. Neuromodulation for Tinnitus Treatment: An Update on Invasive and Non-invasive Strategies-
Tobias Kleinjung, M.D.
5:00-5:30 p.m. The Advantages of Binocular Video Head Impulse Test-Maja Stříteská, M.D.
5:30-6:00 p.m. A Distinctive Pattern in Video Head Impulse Testing Hints Towards a Central Cause in an Acute Vertigo Patient-Vincent Wettstein, M.D.
6:00-6:30 p.m. The Role of Omohyoid Muscle Entrapment of the Internal Jugular Vein and its Surgical Transection in Ménière’s Disease and Other Inner Ear Disorders-G. N. Frau, M.D.
Dinner – 7:30 p.m.
Friday, March 17
Breakfast – 7 a.m.
MORNING SESSION: MANAGEMENT OF MÉNIÈRE’S DISEASE AND OTHER INNER EAR DISORDERS
7:30-8:00 a.m. Audiological Outcomes of Middle Cranial Fossa CSF Leak Repair-Jia Hui Ng, M.D. 8:00-8:30 a.m. Intratympanic Corticosteroids in Ménière’s Disease-Tatjana Tomanovic, M.D.
8:30-9:00 a.m. Intratympanic Iatanoprost for Ménière’s Disease: A Prospective Randomized, Double-blind, Placebo-controlled, Parallel Group Study-Mikael Karlberg, M.D.
9:00-9:30 a.m. Clinical Features and Management of Ménière’s Disease Patients with Drop Attacks-
Chunfu Dai, M.D.
EVENING SESSION: TREATMENT FOR MENIERE’S DISEASE
4:30-5:00 p.m. Chronic Cerebro Spinal Venous Insufficiency (CCSVI), Anatomical Variants and Ménière’s Disease: A New Way to Think the Management of Ménière’s Disease Patients-G.N. Frau, M.D.
5:00-5:30 p.m. The Evidence for Cannabis in the Medical Management of Neurotology Complaints-
Brian McKinnon, M.D.
5:30-6:00 p.m. Monoclonal Antibodies and Sensorineural Hearing Loss-Dennis Fitzgerald, M.D.
6:00-6:30 p.m. Protection of the Auditory Nerve Following Gelfoam-mediated Neurotropic Treatment in Deafened Guinea Pigs-Hans Thomeer, M.D.
Dinner – 7:30 p.m.